1986
DOI: 10.1016/0035-9203(86)90277-4
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of the interaction of leucocytes from Chagas disease patients with trypomastigotes of Trypanosoma cruzi

Abstract: We developed a method to asses the infectivity of Trypanosoma cruzi trypomastigotes for cultured Vero cells, after incubation under different conditions with human leucocyte populations. Total leucocytes, polymorphonuclear (PMN) and mononuclear (MN) cells, from either infected (INF) or cardiomyopathic (CDM) Chagas patients were tested in the presence or absence of autologous serum. Both patient groups had positive complement fixation tests (CFT) for T. cruzi and these were compared with a group of normal contr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1991
1991
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…It is possible that monocytes from cardiac-disease patients have a lower phagocytic ability than those from noninfected individuals or that they express smaller numbers of molecules involved with T. cruzi infection, other than CD11b, such as gp83-TSA ligand. Interestingly, serum from patients with cardiac disease decreased the infection of Vero cells by T. cruzi trypomastigotes (24). Thus, it is also possible that some soluble molecule present in cardiac-disease patients is inhibiting infectivity.…”
Section: Discussionmentioning
confidence: 99%
“…It is possible that monocytes from cardiac-disease patients have a lower phagocytic ability than those from noninfected individuals or that they express smaller numbers of molecules involved with T. cruzi infection, other than CD11b, such as gp83-TSA ligand. Interestingly, serum from patients with cardiac disease decreased the infection of Vero cells by T. cruzi trypomastigotes (24). Thus, it is also possible that some soluble molecule present in cardiac-disease patients is inhibiting infectivity.…”
Section: Discussionmentioning
confidence: 99%